Context Therapeutics

Context Therapeutics Inc. is a women’s oncology company developing advanced small molecule and immunotherapies to transform the care of hormone-driven breast and gynecological cancers. Context’s lead program, Apristor (Onapristone XR), is an investigational drug for the prevention and treatment of ovarian cancer, uterine cancer (endometrial cancer), and breast cancer.